Peter Ashley Marks - 31 Aug 2026 Form 4 Insider Report for ALTERITY THERAPEUTICS LTD (ATHE)

Reporting relationship
Director
Issuer ticker
ATHE
Reported as of
31 Aug 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Sep 2026, 19:01:39 UTC
Prior SEC filing
10 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Peter Ashley Marks

Key filing fact

Peter Ashley Marks filed Form 4 for ALTERITY THERAPEUTICS LTD (ATHE) on 08 Sep 2026.

Key facts

  • This page summarizes Peter Ashley Marks's Form 4 filing for ALTERITY THERAPEUTICS LTD (ATHE).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 08 Sep 2026, 19:01.

Change

  • Previous filing in this sequence was filed on 10 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002127888 Primary reporting owner

Marks Peter Ashley

Relationship
Director
Address
LEVEL 15, 500 COLLINS STREET, MELBOURNE, AUSTRALIA
Signature
Peter Ashley Marks
Signature date
08 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATHE transaction

Ordinary shares

Purchase

Transaction value
Shares
+47,620
Change %
+33%
Price
$0.5000*
Shares after
191,340
Date
31 Aug 2026
Ownership
Lampam Pty Ltd

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATHE transaction Derivative

Listed option exp 31 Aug 2026

Purchase

Transaction value
Shares
-47,620
Change %
-100%
Price
$0.5000*
Shares after
0
Date
31 Aug 2026
Ownership
Lampam Pty Ltd
Underlying class
Ordinary shares
Underlying amount
47,620
Exercise price
$0.5000
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .